Investec Asset Management LTD acquired a new position in shares of Hologic, Inc. (NASDAQ:HOLX) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,701,348 shares of the company’s stock, valued at approximately $68,258,000.
A number of other large investors have also recently modified their holdings of the stock. Korea Investment CORP boosted its stake in shares of Hologic by 58.7% in the third quarter. Korea Investment CORP now owns 112,200 shares of the company’s stock worth $4,357,000 after buying an additional 41,500 shares in the last quarter. State Treasurer State of Michigan boosted its stake in shares of Hologic by 14.8% in the third quarter. State Treasurer State of Michigan now owns 96,800 shares of the company’s stock worth $3,759,000 after buying an additional 12,500 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Hologic by 16.1% in the third quarter. Principal Financial Group Inc. now owns 433,172 shares of the company’s stock worth $16,820,000 after buying an additional 59,952 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of Hologic by 5.7% in the third quarter. Bank of Montreal Can now owns 1,605,058 shares of the company’s stock worth $62,323,000 after buying an additional 86,170 shares in the last quarter. Finally, California State Teachers Retirement System boosted its stake in shares of Hologic by 0.8% in the third quarter. California State Teachers Retirement System now owns 595,624 shares of the company’s stock worth $23,128,000 after buying an additional 5,000 shares in the last quarter. Institutional investors own 94.09% of the company’s stock.
Shares of Hologic, Inc. (NASDAQ:HOLX) traded up 0.23% during mid-day trading on Monday, hitting $40.02. The stock had a trading volume of 1,388,231 shares. The company has a 50 day moving average price of $39.97 and a 200 day moving average price of $38.78. The firm has a market cap of $11.18 billion, a P/E ratio of 34.21 and a beta of 1.10. Hologic, Inc. has a 12-month low of $31.84 and a 12-month high of $41.24.
Hologic (NASDAQ:HOLX) last announced its quarterly earnings results on Wednesday, February 1st. The company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.01. Hologic had a return on equity of 27.17% and a net margin of 11.57%. The company earned $734.40 million during the quarter, compared to analysts’ expectations of $725.01 million. During the same quarter in the previous year, the firm earned $0.46 earnings per share. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. Equities analysts forecast that Hologic, Inc. will post $1.92 earnings per share for the current fiscal year.
This article was originally posted by sleekmoney and is owned by of sleekmoney. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright & trademark laws. The correct version of this article can be viewed at http://sleekmoney.com/investec-asset-management-ltd-buys-new-stake-in-hologic-inc-holx/1658819.html.
A number of research analysts have recently issued reports on HOLX shares. Piper Jaffray Companies raised Hologic from a “neutral” rating to an “overweight” rating and boosted their target price for the company from $44.00 to $48.00 in a report on Wednesday, January 4th. Zacks Investment Research raised Hologic from a “hold” rating to a “strong-buy” rating and set a $45.00 target price on the stock in a report on Tuesday, January 24th. Evercore ISI lowered Hologic from a “buy” rating to a “hold” rating and set a $42.00 target price on the stock. in a report on Wednesday, January 4th. Canaccord Genuity set a $48.00 target price on Hologic and gave the company a “buy” rating in a report on Thursday, December 15th. Finally, Barclays PLC reissued a “buy” rating and issued a $45.00 target price on shares of Hologic in a report on Thursday, November 3rd. Six equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Hologic currently has a consensus rating of “Buy” and an average price target of $44.36.
In other Hologic news, VP Karleen Marie Oberton sold 3,023 shares of the business’s stock in a transaction dated Monday, November 21st. The stock was sold at an average price of $38.32, for a total value of $115,841.36. Following the completion of the sale, the vice president now owns 13,260 shares of the company’s stock, valued at $508,123.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Elaine Ullian sold 9,423 shares of the business’s stock in a transaction dated Friday, February 3rd. The stock was sold at an average price of $39.54, for a total value of $372,585.42. Following the completion of the sale, the director now directly owns 36,798 shares of the company’s stock, valued at approximately $1,454,992.92. The disclosure for this sale can be found here. Insiders sold 13,657 shares of company stock valued at $532,689 in the last ninety days. Insiders own 0.79% of the company’s stock.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/investec-asset-management-ltd-buys-new-stake-in-hologic-inc-holx/1658819.html
Receive News & Ratings for Hologic Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic Inc. and related companies with MarketBeat.com's FREE daily email newsletter.